BioLife Solutions, Inc. (BLFS)

Every figure this model derived for BLFS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 9,478,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 82,416,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 135,198,000 AssetsCurrent 2026-06-30
current liabilities 13,947,000 LiabilitiesCurrent 2026-06-30
equity 420,003,000 StockholdersEquity 2026-06-30
interest expense 385,000 InterestPaidNet 2026-06-30
ocf 16,877,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 102,818,000 RevenueFromContractWithCustomerIncludingAssessedTax 2026-06-30
sbc 21,641,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BLFS on one particular measure came for.

RatioValue
cash operating margin24.38
current ratio9.83
current ratio reported9.69
deferred revenue growth16.05
dilution pct5.6
fcf margin7.2
growth cv2.28
interest cover4.54
operating margin1.7
owner earnings margin-13.85
revenue growth25.4
revenue growth per share18.75
roic0.41
rule of 4027.1
sbc pct revenue21.05

What to be careful about

What this model itself distrusts about BLFS's figures. Written by the derivation as it ran, not added afterwards.